Krsnaa Diagnostics reported a decline in consolidated net profit for the first quarter of FY27 (quarter ended June 30, 2026), posting ₹166 million compared to ₹205 million in the corresponding period last year. Despite the dip in bottom-line figures, the company saw significant growth in its top line, with revenue rising to ₹2.35 billion from ₹1.9 billion year-on-year.

The company published these unaudited standalone and consolidated financial results on August 15, 2026. The newspaper advertisements were placed in Financial Express and Loksatta, pursuant to Regulation 47 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The divergence between revenue growth and profit contraction highlights a squeeze on operating margins. While EBITDA increased to ₹580 million from ₹513 million in the prior year, the EBITDA margin narrowed to 24.6% from 26.58%. This suggests that costs rose at a faster pace than revenues during the period.

Financial Highlights

What the Numbers Show

The data reveals a clear decoupling between revenue expansion and profitability. Revenue grew by approximately 23.7%, significantly outpacing the 13.1% growth in EBITDA. This gap resulted in a margin compression of nearly 200 basis points. The net profit decline of 19% further underscores that the operational gains were not sufficient to offset the higher cost base or other expenses impacting the final bottom line.

Krsnaa Diagnostics has significantly expanded its diagnostic footprint in Himachal Pradesh by securing a Public Private Partnership (PPP) Agreement with the Director Health Services, Health & Family Welfare Department, Government of Himachal Pradesh. The deal involves setting up, operating, managing, maintaining, and reporting CT Scan Diagnostic Facilities at 34 Government Health Institutions across the state, replacing an earlier arrangement that covered only 12 institutions. This expansion underscores the company’s growing dominance in public-sector healthcare partnerships and reinforces its position as a preferred service provider for diagnostics in the region.

The agreement was disclosed on July 23, 2026, pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The project will be implemented on a PPP basis for an initial period of seven years, extendable by a further three years on mutually agreed terms. Notably, the contract operates on a majority cash basis, providing greater revenue visibility compared to purely reimbursement-based models.

Key Contract Details

The expansion from 12 to 34 institutions represents a substantial increase in operational scale for Krsnaa Diagnostics . The company described this as one of the largest government partnerships undertaken for CT Scan diagnostic services. The move demonstrates the company's ability to successfully renew and scale up existing contracts, aligning with its strategic focus on healthcare excellence and expanded geographic reach within Himachal Pradesh.

Strategic Implications

The shift to a majority cash basis is a material development for the company’s cash flow dynamics in the state. Unlike traditional government contracts that may rely heavily on delayed reimbursements, a cash-based model suggests immediate or near-immediate revenue realization from end-users, potentially improving working capital efficiency. The extension option of three years provides long-term stability, allowing for better amortization of capital expenditures required for setting up the new facilities.

This partnership consolidates Krsnaa Diagnostics' presence in Himachal Pradesh, a key market for rural and semi-urban healthcare expansion. By scaling up from 12 to 34 locations, the company is likely to achieve economies of scale in operations and maintenance, further strengthening its competitive moat against private players in the region. The absence of promoter interest or related-party transactions in this award ensures the deal is conducted at arm's length, reflecting genuine market demand for the company's services.